RNA, U6 small nuclear 216, pseudogene (RNU6-216P)

RNU6-216P (RNA, U6 small nuclear 216, pseudogene) is a member of the family of U6 small nuclear RNA (snRNA) pseudogenes. U6 snRNA is an essential component of the spliceosome, the molecular machine responsible for splicing pre-mRNA by removing introns during post-transcriptional modification in the eukaryotic nucleus[3][1]. In contrast, RNU6-216P represents a non-functional, processed pseudogene variant of U6 snRNA, which means it is a sequence in the genome that resembles a functional U6 snRNA gene but is not itself transcribed into functional RNA or protein[4][5]. Pseudogenes like RNU6-216P typically arise through gene duplication or retrotransposition events and accumulate mutations that preclude functional activity[2]. While some pseudogenes have regulatory roles or serve as decoys for microRNAs (miRNA), there is no evidence that RNU6-216P has such functions, nor is it implicated in any disease or targeted by any drugs. Its identification is primarily of interest for genome annotation and the study of pseudogene evolution. Key Notes: - RNU6-216P should not be confused with the functional U6 snRNA, which is integral to the spliceosome and pre-mRNA splicing[1][3]. - There is no reported therapeutic relevance, biomarker status, or directly associated drug interaction. - No evidence of errors or misnaming; this pseudogene is a legitimate entry in genomic databases[4].

Other names

RNU6-216P

Not applicable (no drugs known to target this molecule)